TITLE

Cancer-related direct-to-consumer advertising: a critical review

AUTHOR(S)
Kontos, Emily Z.; Viswanath, K.
PUB. DATE
February 2011
SOURCE
Nature Reviews Cancer;Feb2011, Vol. 11 Issue 2, p142
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The direct-to-consumer advertising (DTCA) phenomenon has received attention because of its attempt to reach out to consumers by bypassing important gatekeepers such as physicians. The emergence of new information platforms and the introduction of genetic tests directly to the consumer have heightened the concern with DTCA and its potential consequences. These effects of DTCA are particularly important given the communication inequalities among social groups, with class, race and ethnicity influencing how people access, seek, process and act on information. This Science and Society article reviews the major issues regarding general and cancer-related DTCA and also offers data from a national survey in the United States as an example of the communication inequalities in genetic testing awareness.
ACCESSION #
57511926

 

Related Articles

  • Direct-access genetic testing: the view from Europe. Kricka, Larry J.; Fortina, Paolo; Mai, Yuan; Patrinos, George P. // Nature Reviews Genetics;Oct2011, Vol. 12 Issue 10, p670 

    The article discusses the comparison of direct-to-consumer (DTC) genetic testing in Europe and in North America. It says that DTC genetic testing in the U.S. has received an intense examination in terms of legality, reliability, and benefits to the patients. It mentions that in Europe, it is...

  • Myths, Misconceptions and Myopia: Searching for Clarity in the Debate about the Regulation of Consumer Genetics. Hogarth, S. // Public Health Genomics;2010, Vol. 13 Issue 5, p322 

    The new wave of companies offering genome scans direct-to-consumer (DTC) has prompted commentary from scientists, clinicians, bioethicists and those interested in the ethical, legal and social issues arising from genomics. It has thus brought a far wider range of actors into a longstanding...

  • Health-Related Direct-to-Consumer Genetic Tests: A Public Health Assessment and Analysis of Practices Related to Internet-Based Tests for Risk of Thrombosis. Goddard, K. A. B.; Robitaille, J.; Dowling, N. F.; Parrado, A. R.; Fishman, J.; Bradley, L. A.; Moore, C. A.; Khoury, M. J. // Public Health Genomics;2009, Vol. 12 Issue 2, p92 

    Background: Recent years have seen increased concern about direct-to-consumer (DTC) genetic testing (i.e., the sale and use of genetic tests without involving a health care provider). Numerous professional organizations have developed policies in this area. However, little systematic evidence...

  • Single-institution study: About 86% of patients aware of DTC advertising. Adams, Stacey L.; Harris, Jason; Haigh, Christen // Hem/Onc Today;9/10/2009, Vol. 10 Issue 17, p26 

    The article presents findings of a survey on the exposure of patients to cancer-related direct-to-consumer advertising.

  • An agenda for personalized medicine. Ng, Pauline C.; Murray, Sarah S.; Levy, Samuel; Venter, J. Craig // Nature;10/8/2009, Vol. 461 Issue 7265, p724 

    The article offers information on direct-to-consumer (DTC) genetics-testing companies, 23andMe Inc. in Mountain View, California and Navigenics Inc. in Foster City, California as well as some concerns in the industry. Based on the assessment, the accuracy of the raw datas from DTC are high and...

  • Drug advertising guidelines draw criticism. Wechler, Jill // Managed Healthcare Executive;Sep2005, Vol. 15 Issue 9, p5 

    Reports on pharmaceutical marketers' guidelines that support the basic premise that direct-to-consumer (DTC) drug advertising is beneficial. Advice to drug marketers to present balanced advertisements that disclose risks and benefits; Advice against posting "reminder advertisements"; Targeting...

  • Dose of reality. Goetzl, David; Klaassen, Abbey; Teinowitz, Ira; Sanders, Lisa // Advertising Age;7/23/2001, Vol. 72 Issue 30, p1 

    The article reports on the slowdown of the direct-to-consumer (DTC) drug advertising sector. DTC spending grew 10 per cent during the first quarter of 2001, but the growth is still minimal compared with the past few years. Several factors are being cited by industry executives for the slowdown...

  • OTC drugs head online. Mack, Jonathan // DM News;3/9/2009, p13 

    The article focuses on the growing online presence of over-the-counter drug (OTC) marketers. Experts say that the shift from traditional mass media advertising to using the Internet has been compelling because of its efficiency and measurability. The relationship between the OTC brand and the...

  • DTC spend leveling off, marketers say. M. A. // Medical Marketing & Media;May2006, Vol. 41 Issue 5, p30 

    The article reports on the results of a study by research firm, Optas, which showed that direct-to-consumer (DTC) spending is leveling off. However, the study showed that integrated direct-to-patient programs combining in-office, e-mail and Web channels are expected to register significant...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics